SCHEMBL6552573

SCHEMBL6552573

CCCCCCC=COC(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOAT2 O75908 1/20 0.49
SOAT1 P35610 1/20 0.49
EPHX2 P34913 4/20 0.48
FAAH O00519 2/20 0.48
CNR1 P21554 1/20 0.48
CNR2 P34972 1/20 0.48
ALDH1A1 P00352 5/20 0.47
PPARG P37231 4/20 0.47
F7 P08709 3/20 0.47
F3 P13726 3/20 0.47
PPARD Q03181 3/20 0.47
PPARA Q07869 3/20 0.47
LMNA P02545 3/20 0.47
KDM4E B2RXH2 2/20 0.47
FFAR1 O14842 2/20 0.47
CYP3A4 P08684 2/20 0.47
CYP19A1 P11511 2/20 0.47
FABP4 P15090 2/20 0.47
HPGD P15428 2/20 0.47
ALOX15 P16050 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21528269 1.00 SOAT2 (0.49) SOAT2SOAT1EPHX2FAAHCNR1
SCHEMBL6552788 1.00 SOAT2 (0.49) SOAT2SOAT1EPHX2FAAHCNR1
SCHEMBL6552638 1.00 SOAT2 (0.49) SOAT2SOAT1EPHX2FAAHCNR1
SCHEMBL22439055 1.00 SOAT2 (0.49) SOAT2SOAT1EPHX2FAAHCNR1
SCHEMBL6552841 1.00 SOAT2 (0.49) SOAT2SOAT1EPHX2FAAHCNR1
SCHEMBL6552826 1.00 SOAT2 (0.49) SOAT2SOAT1EPHX2FAAHCNR1
SCHEMBL6551288 0.98 LMNA (0.47) SOAT2SOAT1EPHX2FAAHCNR1
SCHEMBL7934397 0.94 LMNA (0.49) SOAT2SOAT1EPHX2FAAHCNR1
SCHEMBL7934395 0.94 LMNA (0.49) SOAT2SOAT1EPHX2FAAHCNR1
SCHEMBL20503355 0.87 LMNA (0.51) ALDH1A1LMNACYP3A4HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250270470-A1 METHOD FOR RELEASING ALDEHYDE OR KETONE TAKASAGO INTERNATIONAL CORPORATION (JP) 2025-08-28 US disclosed
US-12319891-B2 Method for releasing aldehyde or ketone TAKASAGO INTERNATIONAL CORPORATION (JP) 2025-06-03 US disclosed
US-20210348081-A1 METHOD FOR RELEASING ALDEHYDE OR KETONE TAKASAGO INTERNATIONAL CORPORATION (JP) 2021-11-11 US disclosed
EP-3572518-A1 METHOD FOR RELEASING ALDEHYDE OR KETONE Takasago International Corporation (JP) 2019-11-27 EP disclosed
US-20190338216-A1 METHOD FOR RELEASING ALDEHYDE OR KETONE TAKASAGO INTERNATIONAL CORPORATION (JP) 2019-11-07 US disclosed
EP-1048457-B1 Lithographic printing plate precursor FUJI PHOTO FILM CO LTD (JP) 2004-12-15 EP disclosed
US-6455224-B1 SUPPORT WITH HYDROPHILIC SURFACE AND PHOTOSENSITIVE LAYER CONTAINING INFRARED ABSORBENT WHICH CHANGES FROM HYDROPHILIC TO HYDROPHOBIC BY HEAT AND HYDROPHILIC POLYMER HAVING FUNCTIONAL GROUP RENDERING LAYER WATER DEVELOPABLE FUJI PHOTO FILM CO., LTD. (JP) 2002-09-24 US disclosed
EP-1048457-A2 Lithographic printing plate precursor FUJI PHOTO FILM CO., LTD. (JP) 2000-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12319891-B2 Method for releasing aldehyde or ketone APEH, AKR7A2, FAAH2 SOAT2 1264/4885SOAT1 1176/4885EPHX2 214/4885
US-20190338216-A1 METHOD FOR RELEASING ALDEHYDE OR KETONE APEH, AKR1C3, AKR7A2 SOAT2 1665/4885SOAT1 1440/4885EPHX2 170/4885
US-20250270470-A1 METHOD FOR RELEASING ALDEHYDE OR KETONE APEH, AKR7A2, FAAH2 SOAT2 1264/4885SOAT1 1176/4885EPHX2 214/4885
US-20210348081-A1 METHOD FOR RELEASING ALDEHYDE OR KETONE APEH, AKR7A2, FAAH2 SOAT2 1264/4885SOAT1 1176/4885EPHX2 214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.